切换至 "中华医学电子期刊资源库"

中华脑科疾病与康复杂志(电子版) ›› 2024, Vol. 14 ›› Issue (01) : 1 -7. doi: 10.3877/cma.j.issn.2095-123X.2024.01.001

述评

中小型前庭神经鞘瘤治疗方式选择的原则和依据
陈立华()   
  1. 610072 成都,四川省医学科学院·四川省人民医院神经外科
  • 收稿日期:2023-05-12 出版日期:2024-02-15
  • 通信作者: 陈立华

Principles and basis for selecting treatment methods for small and medium-sized vestibular schwannoma

Lihua Chen()   

  1. Department of Neurosurgery, Sichuan Academy of Medical Sciences·Sichuan Provincial People's Hospital, Chengdu 610072, China
  • Received:2023-05-12 Published:2024-02-15
  • Corresponding author: Lihua Chen
引用本文:

陈立华. 中小型前庭神经鞘瘤治疗方式选择的原则和依据[J]. 中华脑科疾病与康复杂志(电子版), 2024, 14(01): 1-7.

Lihua Chen. Principles and basis for selecting treatment methods for small and medium-sized vestibular schwannoma[J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2024, 14(01): 1-7.

中小型前庭神经鞘瘤(VS)有多种治疗策略,包括显微外科手术(MS)、立体定向放射外科治疗(SRS)和随访观察(CT),其在肿瘤控制和面神经功能方面的结果相似,在疾病控制和并发症方面提供了良好的效果,主要区别在于对听力的保护。目前关于中小型VS最佳的治疗方法仍存在争议,尤其是对听力正常的年轻患者治疗的必要性和听力保护的最佳时机也存有争议,临床上需在个体化地、合理的选择治疗模式。本文对中小型VS的3种治疗模式的优缺点进行总结分析,旨在实现长期功能保存和提高患者的生活质量。

There are various treatment strategies for small and medium-sized vestibular schwannoma (VS), including microsurgery (MS), stereotactic radiosurgery surgery (SRS), and conservative treatment (CT). The three treatment plans have similar results in tumor control and facial nerve function, providing good results in disease control and complications, with the main difference being the protection of hearing. At present, the optimal treatment method for small and medium-sized VS is still controversial, especially for young patients with normal hearing, the necessity of treatment, and the optimal timing for hearing protection. In clinical practice, it is necessary to choose the treatment mode individually and reasonably. This article summarizes and analyzes the advantages and disadvantages of three treatment modes, aiming to achieve long-term functional preservation and improve the quality of life of patients.

[1]
Zhu W, Chen H, Jia H, et al. Long-term hearing preservation outcomes for small vestibular schwannomas: retrosigmoid removal versus observation[J]. Otol Neurotol, 2018, 39(2): e158-e165. DOI: 10.1097/mao.0000000000001684.
[2]
Marinelli JP, Lees KA, Lohse CM, et al. Natural history of growing sporadic vestibular schwannomas: an argument for continued observation despite documented growth in select cases[J]. Otol Neurotol, 2020, 41(9): e1149-e1153. DOI: 10.1097/mao.0000000000002756.
[3]
Olson JJ, Kalkanis SN, Ryken TC. Congress of neurological surgeons systematic review and evidence-based guidelines on the treatment of adults with vestibular schwannomas: executive summary[J]. Neurosurgery, 2018, 82(2): 129-134. DOI: 10.1093/neuros/nyx586.
[4]
Paldor I, Chen AS, Kaye AH. Growth rate of vestibular schwannoma[J]. J Clin Neurosci, 2016, 32: 1-8. DOI: 10.1016/j.jocn.2016.05.003.
[5]
Huo Z, Chen J, Wang Z, et al. Prognostic factors of long-term hearing preservation in small and medium-sized vestibular schwannomas after microsurgery[J]. Otol Neurotol, 2019, 40(7): 957-964. DOI: 10.1097/mao.0000000000002284.
[6]
Kirchmann M, Karnov K, Hansen S, et al. Ten-year follow-up on tumor growth and hearing in patients observed with an intracanalicular vestibular schwannoma[J]. Neurosurgery, 2017, 80(1): 49-56. DOI: 10.1227/neu.0000000000001414.
[7]
Carlson ML, Link MJ, Wanna GB, et al. Management of sporadic vestibular schwannoma[J]. Otolaryngol Clin North Am, 2015, 48(3): 407-422. DOI: 10.1016/j.otc.2015.02.003.
[8]
Peng KA, Wilkinson EP. Optimal outcomes for hearing preservation in the management of small vestibular schwannomas[J]. J Laryngol Otol, 2016, 130(7): 606-610. DOI: 10.1017/s0022215116007969.
[9]
Charabi S, Thomsen J, Tos M, et al. Acoustic neuroma/vestibular schwannoma growth: past, present and future[J]. Acta Otolaryngol, 1998, 118(3): 327-332. DOI: 10.1080/00016489850183395.
[10]
Deberge S, Meyer A, Le Pabic E, et al. Quality of life in the management of small vestibular schwannomas: observation, radiotherapy and microsurgery[J]. Clin Otolaryngol, 2018, 43(6): 1478-1486. DOI: 10.1111/coa.13203.
[11]
Carlson ML, Barnes JH, Nassiri A, et al. Prospective study of disease-specific quality-of-life in sporadic vestibular schwannoma comparing observation, radiosurgery, and microsurgery[J]. Otol Neurotol, 2021, 42(2): e199-e208. DOI: 10.1097/mao.0000000000002863.
[12]
Zanoletti E, Cazzador D, Faccioli C, et al. Multi-option therapy vs observation for small acoustic neuroma: hearing-focused management[J]. Acta Otorhinolaryngol Ital, 2018, 38(4): 384-392. DOI: 10.14639/0392-100x-1756.
[13]
Kiyofuji S, Neff BA, Carlson ML, et al. Large and small vestibular schwannomas: same, yet different tumors[J]. Acta Neurochir (Wien), 2021, 163(8): 2199-2207. DOI: 10.1007/s00701-021-04705-6.
[14]
Lees KA, Tombers NM, Link MJ, et al. Natural history of sporadic vestibular schwannoma: a volumetric study of tumor growth[J]. Otolaryngol Head Neck Surg, 2018, 159(3): 535-542. DOI: 10.1177/0194599818770413.
[15]
Patnaik U, Prasad SC, Tutar H, et al. The long-term outcomes of wait-and-scan and the role of radiotherapy in the management of vestibular schwannomas[J]. Otol Neurotol, 2015, 36(4): 638-646. DOI: 10.1097/mao.0000000000000657.
[16]
Massick DD, Welling DB, Dodson EE, et al. Tumor growth and audiometric change in vestibular schwannomas managed conservatively[J]. Laryngoscope, 2000, 110(11): 1843-1849. DOI: 10.1097/00005537-200011000-00015.
[17]
Patel NS, Huang AE, Dowling EM, et al. The influence of vestibular schwannoma tumor volume and growth on hearing loss[J]. Otolaryngol Head Neck Surg, 2020, 162(4): 530-537. DOI: 10.1177/0194599819900396.
[18]
Hughes M, Skilbeck C, Saeed S, et al. Expectant management of vestibular schwannoma: a retrospective multivariate analysis of tumor growth and outcome[J]. Skull Base, 2011, 21(5): 295-302. DOI: 10.1055/s-0031-1284219.
[19]
Moffat DA, Kasbekar A, Axon PR, et al. Growth characteristics of vestibular schwannomas[J]. Otol Neurotol, 2012, 33(6): 1053-1058. DOI: 10.1097/MAO.0b013e3182595454.
[20]
Fayad JN, Semaan MT, Lin J, et al. Conservative management of vestibular schwannoma: expectations based on the length of the observation period[J]. Otol Neurotol, 2014, 35: 1258-1265. DOI: 10.1097/MAO.0000000000000285.
[21]
Sughrue ME, Yang I, Aranda D, et al. The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes[J]. J Neurosurg, 2010, 112(1): 163-167. DOI: 10.3171/2009.4.Jns08895.
[22]
Varughese JK, Breivik CN, Wentzel-Larsen T, et al. Growth of untreated vestibular schwannoma: a prospective study[J]. J Neurosurg, 2012, 116(4): 706-712. DOI: 10.3171/2011.12.Jns111662.
[23]
Charabi S, Thomsen J, Mantoni M, et al. Acoustic neuroma (vestibular schwannoma): growth and surgical and nonsurgical consequences of the wait-and-see policy[J]. Otolaryngol Head Neck Surg, 1995, 113(1): 5-14. DOI: 10.1016/s0194-59989570138-9.
[24]
Golfinos JG, Hill TC, Rokosh R, et al. A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas[J]. J Neurosurg, 2016, 125(6): 1472-1482. DOI: 10.3171/2015.12.Jns151857.
[25]
Schwartz MS, Lekovic GP, Miller ME, et al. Translabyrinthine microsurgical resection of small vestibular schwannomas[J]. J Neurosurg, 2018, 129(1): 128-136. DOI: 10.3171/2017.2.Jns162287.
[26]
Scheich M, Ehrmann-Müller D, Shehata-Dieler W, et al. Hearing results after middle fossa removal of small (T1/T2) vestibular schwannomas[J]. HNO, 2017, 65(9): 751-757. DOI: 10.1007/s00106-016-0228-5.
[27]
Mazzoni A, Zanoletti E, Denaro L, et al. Retrolabyrinthine meatotomy as part of retrosigmoid approach to expose the whole internal auditory canal: rationale, technique, and outcome in hearing preservation surgery for vestibular schwannoma[J]. Oper Neurosurg (Hagerstown), 2018, 14(1): 36-44. DOI: 10.1093/ons/opx091.
[28]
Zanoletti E, Mazzoni A, d'Avella D. Hearing preservation in small acoustic neuroma: observation or active therapy? Literature review and institutional experience[J]. Acta Neurochir (Wien), 2019, 161(1): 79-83. DOI: 10.1007/s00701-018-3739-x.
[29]
Mazzoni A, Zanoletti E, Calabrese V. Hearing preservation surgery in acoustic neuroma: long-term results[J]. Acta Otorhinolaryngol Ital, 2012, 32(2): 98-102.
[30]
Carlson ML, Vivas EX, McCracken DJ, et al. Congress of neurological surgeons systematic review and evidence-based guidelines on hearing preservation outcomes in patients with sporadic vestibular schwannomas[J]. Neurosurgery, 2018, 82(2): E35-E39. DOI: 10.1093/neuros/nyx511.
[31]
Han MS, Jung S, Lim SH, et al. What clinicians should consider to determine a more beneficial treatment strategy for small to medium sized vestibular schwannoma with serviceable hearing: a single surgeon's long-term outcome of microsurgery and gamma knife radiosurgery[J]. Otol Neurotol, 2020, 41(8): 1122-1130. DOI: 10.1097/mao.0000000000002721.
[32]
Mastronardi L, Di Scipio E, Cacciotti G, et al. Hearing preservation after removal of small vestibular schwannomas by retrosigmoid approach: comparison of two different ABR neuromonitoring techniques[J]. Acta Neurochir (Wien), 2019, 161(1): 69-78. DOI: 10.1007/s00701-018-3740-4.
[33]
Carlson ML, Tveiten ØV, Lund-Johansen M, et al. Patient motivation and long-term satisfaction with treatment choice in vestibular schwannoma[J]. World Neurosurg, 2018, 114: e1245-e1252. DOI: 10.1016/j.wneu.2018.03.182.
[34]
Link MJ, Lund-Johansen M, Lohse CM, et al. Quality of life in patients with vestibular schwannomas following gross total or less than gross total microsurgical resection: Should we be taking the entire tumor out?[J]. Neurosurgery, 2018, 82(4): 541-547. DOI: 10.1093/neuros/nyx245.
[35]
Macielak RJ, Thao V, Borah BJ, et al. Lifetime cost and quality-adjusted life-years across management options for small- and medium-sized sporadic vestibular schwannoma[J]. Otol Neurotol, 2021, 42(9): e1369-e1375. DOI: 10.1097/mao.0000000000003266.
[1] 张白, 惠品晶, 颜燕红, 丁亚芳, 王润川, 张翌, 黄亚波, 胡春洪, 方琪. 微型探头血管超声在烟雾病患者搭桥术中的血流动力学评估[J]. 中华医学超声杂志(电子版), 2019, 16(09): 676-683.
[2] 刘长瑞, 朱见, 郑振华, 贺青卿. 显微外科技术在乳腺癌相关上肢淋巴水肿中的应用[J]. 中华乳腺病杂志(电子版), 2020, 14(02): 109-111.
[3] 刘林峰, 王增涛, 王云鹏, 钟硕, 郝丽文, 仇申强, 陈超. 足底内侧皮瓣联合甲骨皮瓣在手指V度缺损再造中的临床应用[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 480-484.
[4] 张浩, 张万福, 韩飞, 佟琳, 王运帷, 李少辉, 陈阳, 曹鹏, 官浩. 游离组织瓣治疗无吻合血管或需困难吻合血管创面的临床进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 442-446.
[5] 蒲东全, 刘锐, 胡凯凯, 刘莉, 张琳, 杨琴, 周霞. 上颌侧切牙腭根遗漏、钙化伴侧壁穿孔显微根管外科手术一例[J]. 中华口腔医学研究杂志(电子版), 2021, 15(01): 34-39.
[6] 李晓东, 魏云. 冠状切口额下入路治疗前颅窝巨大脑膜瘤[J]. 中华神经创伤外科电子杂志, 2023, 09(05): 318-319.
[7] 云望, 乔卫东, 李钢. 髓母细胞瘤显微手术切除[J]. 中华神经创伤外科电子杂志, 2021, 07(05): 318-320.
[8] 黄银兴, 刘峥, 陈其钻, 张尚明, 田君, 薛亮, 王守森. 显微外科手术治疗复杂性脑挫裂伤[J]. 中华神经创伤外科电子杂志, 2021, 07(01): 21-24.
[9] 李钢. 颞叶实质性血管母细胞瘤手术切除[J]. 中华神经创伤外科电子杂志, 2020, 06(02): 124-127.
[10] 李俊, 马廉亭. 多模态三维影像融合技术体系的建立及在脑血管病诊疗中的应用[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(03): 129-134.
[11] 陈立华, 夏勇, 魏帆, 孙恺, 黄宏志. 前床突脑膜瘤术后视力的影响因素研究[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(06): 332-337.
[12] 许骏, 于炎冰. 腰骶段选择性脊神经后根部分切断术治疗下肢痉挛状态[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(03): 190-192.
[13] 冯兆海, 裴祎楠, 哈里木热提·帕尔哈提, 郝玉军, 姜磊. 术中神经电生理监测相关危险因素分析及预防策略[J]. 中华脑科疾病与康复杂志(电子版), 2021, 11(04): 232-236.
[14] 陈立华, 孙恺, 张洪钿, 陈文锦, 徐如祥. 鞍结节脑膜瘤经颅手术入路的选择[J]. 中华脑科疾病与康复杂志(电子版), 2020, 10(01): 38-43.
[15] 张治家, 刘洁, 郭芳芳, 李德保. 股前外侧皮瓣带血管化的阔筋膜在跟腱及软组织缺损中的应用[J]. 中华临床医师杂志(电子版), 2019, 13(12): 918-921.
阅读次数
全文


摘要